6 results
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Resistant Tuberculosis ... #MDRTB #management ... #pharmacology #dosing
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... involvement - seeding ... characteristic features Clinical ... Treatment: Active ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... involvement - seeding ... characteristic features Clinical ... Treatment: Active ... #Management #Treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... HIV-infected persons with clinical ... drug dosing recommendations ... Mycobacterium #Tuberculosis ... #Treatment #management
Induction agents used in anesthesia play a key role in the eventual sedation of the patient,
of the patient, leading ... #clinical #management ... Amidate (etomidate) dosing ... reference.medscape.com/drug ... Effects, Dosages, Treatment
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
disease based on clinical ... to Table 5 for dosing ... Note: Active TB ... IDSA #Prevention #Treatment ... #management #opportunistic